For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development-Nonrelated Party | 22,964 | |||
| Research and development - related parties note 11-Related Party | 34 | |||
| General and administrative-Nonrelated Party | 31,868 | |||
| General and administrative - related parties note 11-Related Party | 14 | |||
| Total operating expenses | 54,880 | |||
| Interest income | 1,495 | |||
| Interest expense note 8 | 819 | |||
| Change in fair value of contingent consideration note 5 and note 6 | 408 | |||
| Other income (expense) | -36 | |||
| Total other income (expense) | 232 | |||
| Net loss | -54,648 | |||
| Basic EPS | -1.25 | |||
| Diluted EPS | -1.25 | |||
| Basic Average Shares | 43,594,652 | |||
| Diluted Average Shares | 43,594,652 | |||
ACHIEVE LIFE SCIENCES, INC. (ACHV)
ACHIEVE LIFE SCIENCES, INC. (ACHV)